The country has already developed a new HIV Vaccine Plan to boost
research into drugs that could tackle the HIV strains that are peculiar
to Nigeria and West Africa.
Study Coordinator of the
Nigeria-Canadian Collaborative AIDS Vaccine Project (NICCAV), Dr Eva
Okpokoro, at a media roundtable in Abuja yesterday said that the project
is looking at working with a cohort of sero-discordant couples over the
next three years in preparation for HIV vaccine trial in Nigeria.
“The project has three targets: clinical
research, ethics and regulation, community mobilization and research
laboratory international certification,” he said.
On the HIV vaccine, Dr. Morenike Ukpong
of the New HIV Vaccine and Microbicide Advocacy Society (NHVMAS)
stressed the need and eagerness of stakeholders to develop a vaccine for
Nigeria because of the peculiarities of the HIV strain the country, and
the West African region as a whole.
She said “Even if we have eventually
developed a vaccine globally, it may not be applicable to Nigeria
because we have a peculiar vaccine strain that needs special research
efforts.”
She said NHVMAS was born out of a
collective vision of a few Nigerian activists to ensure proactive and
early involvement of the Nigerian government and its citizens in New HIV
prevention technology research and development.
The Ministries of Health, Science &
Technology, Education, Information as well as NACA and other government
agencies will be principally involved in the implementation of the
National HIV Vaccine Plan.
No comments:
Post a Comment